article thumbnail

FOPE & PharmaState Academy hosts session 15 PULSE Program

Express Pharma

One of the practical challenges discussed was the implementation of personal and material airlocks in small pharmaceutical companies, where the panel addressed space constraints and suggested viable alternatives such as dynamic pass boxes and modular cubicles for material transfer.

article thumbnail

The Issue with Reissue: PTE Edition

FDA Law Blog: Biosimilars

Specifically, the Court focused on the purpose: to compensate pharmaceutical companies for the effective truncation of their patent terms while waiting for regulatory approval of new drug applications. The question is important because the result of that determination could drastically reduce the amount of patent term to be restored.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

Pharmacy Times

The Orange Book is the reference, and it allows the FDA to declare something [to be] therapeutically equivalent. In 2022, based upon a complaint filed by a pharmaceutical company, CMS was asked to reevaluate the SSA section that establishes the J-code,” Soefje said. If it’s a sole-source drug, it gets its own unique J-code.

article thumbnail

The Importance of Modernizing Your Email Marketing Campaigns

Pharma Marketing Network

downloads, appointment bookings) Email heat maps and click maps These insights help marketers understand which content works, when to send messages, and how to refine future campaigns. These outdated approaches often result in low open rates, unsubscribes, and missed opportunities.

HIPAA 52
article thumbnail

Barriers are limiting UK childhood vaccination, say doctors

pharmaphorum

Skip to main content Tuesday 1 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

article thumbnail

STAT+: Pharmalittle: We’re reading about a FDA offer on drug reviews, a Moderna Covid approval, and more

STAT

You could also take a moment to curl up with a good book or perhaps enjoy some scrumptious food. Food and Drug Administration Commissioner Marty Makary said the agency may fast-track new drugs from pharmaceutical companies that “equalize” the cost of their medicines between the U.S. See you soon.

Vaccines 157
article thumbnail

STAT+: FTC warns drugmakers they can face legal action over improper patent listings

STAT

The Federal Trade Commission warned pharmaceutical companies they could face legal action if they improperly list patents for brand-name medicines in a Food and Drug Administration registry, the latest effort by the federal government to scrutinize patent moves by drugmakers. Continue to STAT+ to read the full story…